Keyphrases
Activation Markers
100%
Alzheimer's Disease
100%
Associated Antigen
33%
CD-8
66%
CD42
33%
Disease Severity
33%
Disease Stage
100%
Elderly Controls
33%
Group Support
33%
HLA-DR
66%
Immune Response
33%
Immunological Parameters
33%
Interleukin-2
33%
Lymphocytes
100%
Mild Stage
33%
Mitogen
66%
Peripheral Immune Cells
33%
Peripheral Lymphocytes
33%
Proliferative Activity
33%
Receptor Expression
33%
Severe Group
33%
Severe Stage
33%
Soluble interleukin-2 Receptor (sIL-2R)
66%
T Lymphocyte Activation
100%
T Lymphocyte Subpopulations
100%
Medicine and Dentistry
Alzheimer's Disease
100%
CD8 Antigen
66%
Clinical Stage
33%
Diseases
100%
Interleukin 2
33%
Interleukin 2 Receptor
66%
Lymphocyte
100%
Mitogenic Agent
66%
Patient with Alzheimer's Disease
33%
Peripheral Lymphocyte
33%
Phytohaemagglutinin
33%
Receptor Expression
33%
Secretion (Process)
33%
T Lymphocyte Activation
100%
T Lymphocyte Subpopulation
100%
Immunology and Microbiology
CD4
66%
CD8
66%
HLA-DR
66%
Interleukin 2
33%
Interleukin 2 Receptor
66%
Lymphocyte
100%
Mitogen
66%
Peripheral Blood Lymphocyte
33%
Phytohaemagglutinin
33%
Secretion (Process)
33%
T Lymphocyte Activation
100%
T Lymphocyte Subpopulation
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
CD8 Antigen
66%
Diseases
100%
Interleukin 2
33%
Interleukin 2 Receptor
66%
Mitogenic Agent
66%
Phytohaemagglutinin
33%
Veterinary Science and Veterinary Medicine
CD4
66%
Lymphocyte
100%
Peripheral Blood Lymphocyte
33%
T Cell
100%